The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phoxillum B22k4/0
magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate · MAGNESIUM CHLORIDE 3.05 g/L; SODIUM CHLORIDE 6.95 g/L; SODIUM BICARBONATE 2.21 g/L; POTASSIUM CHLORIDE .314 g/L; SODIUM PHOSPHATE, DIBASIC .187 g/L · Injection · Intravenous · Vantive US Healthcare LLC
NDC 24571-0117-06 · 2 BAG in 1 CASE / 5 L in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$81.75
Reported to Texas DSHS · 2025 annual filing · Baxter Healthcare Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- NDA207026
- TE code
- —
- Approval date
- Jan 13, 2015
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Vantive US Healthcare LLC | MAGNESIUM CHLORIDE 3.05 g/L; SODIUM CHLORIDE 6.95 g/L; SODIUM BICARBONATE 2.21 g/L; POTASSIUM CHLORIDE .314 g/L; SODIUM PHOSPHATE, DIBASIC .187 g/L | Aug 26, 2026 | Sep 2, 2026 |
| Vantive US Healthcare LLC | MAGNESIUM CHLORIDE 3.05 g/L; SODIUM CHLORIDE .314 g/L; SODIUM BICARBONATE 2.21 g/L; POTASSIUM CHLORIDE 6.95 g/L; SODIUM PHOSPHATE, DIBASIC .187 g/L | Jul 22, 2026 | Aug 19, 2026 |
| Vantive US Healthcare LLC | MAGNESIUM CHLORIDE 3.05 g/L; POTASSIUM CHLORIDE .314 g/L; SODIUM BICARBONATE 2.21 g/L; SODIUM CHLORIDE 6.95 g/L; SODIUM PHOSPHATE, DIBASIC .187 g/L | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phoxillum B22k4/0 — NDC 24571-0117-06," retrieved September 3, 2026, https://drugdashboards.com/drug/24571011706.
Free to cite with attribution — see how the data is put together.